Tiakis Biotech
Kiel, DE · 1 known investors
Tiakis develops investigational therapeutics targeting pulmonary-arterial hypertension and postoperative inflammation using tissue-protective mechanisms derived from clinical research. The company focuses on novel anti-inflammatory drugs for patients with unmet medical needs.
BiotechHealthtechMedical Devices
Investors · 1
Frequently asked questions
- What does Tiakis Biotech do?
- Tiakis develops investigational therapeutics targeting pulmonary-arterial hypertension and postoperative inflammation using tissue-protective mechanisms derived from clinical research. The company focuses on novel anti-inflammatory drugs for patients with unmet medical needs.
- Who are Tiakis Biotech's investors?
- Tiakis Biotech's investors include Elevat3 Capital.
- Where is Tiakis Biotech headquartered?
- Tiakis Biotech is headquartered in Kiel, DE.